BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241202
DTEND;VALUE=DATE:20241205
DTSTAMP:20260515T135909
CREATED:20240808T110905Z
LAST-MODIFIED:20240808T110905Z
UID:39544-1733097600-1733356799@www.pharmajournalist.com
SUMMARY:2nd Cell Therapy for Autoimmune Disease Summit
DESCRIPTION:The 2nd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia bigger and better after last year’s explosive debut as the only meeting covering every aspect of bringing cell therapies to the autoimmune space. \nThis year’s agenda brings you the opportunity to learn the A-Zs of accelerating your candidates to be the first in the market and finally bring the cure for an autoimmune indication. Leading experts including Cartesian Therapeutics\, Bristol Myers Squibb\, the University of Pennsylvania\, ImmPACT Bio and more\, will cover their latest clinical updates\, next-generation candidates\, novel antigen targets\, and translational biomarkers to turbocharge the development of cell therapies for autoimmune disease. \nThis is your chance to connect with top cell therapy pioneers\, clinicians\, investors\, and wavemakers who share a focus on accelerating this approach for autoimmune patients to realize a curative treatment. \nFind out more here.
URL:http://www.pharmajournalist.com/event/2nd-cell-therapy-for-autoimmune-disease-summit/
LOCATION:Sheraton Philadelphia Downtown\, 201 N 17th Street\, Philadelphia\, PA\, 19103\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR